In line with the two-hit model of tumour suppression, the biallelic mutation of NF2 leads to the development of neurofibromatosis type II (NF2) [3], a tumourigenic genetic disease characterised by bilateral schwannoma formation along the vestibulocochlear cranial nerve [4]. The gene discussed is NF2; the disease is NF2-related schwannomatosis.